CoverCress (previously Arvegenix)
Rotational winter oilseed crop for biofuel feedstock
About CoverCress (previously Arvegenix)
CoverCress Inc., formerly Arvegenix, is an agricultural technology company founded in 2013 that has developed a rotational cash crop from field pennycress. Utilizing sophisticated breeding and gene-editing techniques, the company created its namesake crop, CoverCress™, designed to be planted between corn and soybean rotations during the winter. This provides farmers with a third cash crop within a two-year period on existing land, enhancing profitability without interfering with primary crop seasons. The company was founded by a team including Dennis Plummer, Mike Roth, and Vijay Chauhan, with Jerry Steiner later becoming CEO in 2015. The company's development was significantly supported by the St. Louis ag-tech ecosystem, including early funding and management talent from BioGenerator.
The business model centers on creating a new farm-to-fuel supply chain. CoverCress establishes contracts with farmers for grain production, guaranteeing a market and eliminating upfront costs for the growers. After harvest, the grain is sold to partners for processing. The extracted oil serves as a low-carbon-intensity feedstock for renewable diesel and sustainable aviation fuel. The remaining high-protein meal is sold as an animal feed ingredient, comparable to canola meal. This model offers farmers an additional revenue stream while also providing the environmental benefits of a cover crop, such as improved soil health, reduced erosion, and carbon sequestration.
CoverCress has secured significant strategic investment and partnerships, culminating in an August 2022 acquisition that resulted in Bayer becoming the majority owner with a 65% stake. The remaining shares are held by strategic partners Bunge and Chevron. This collaboration solidifies the entire value chain: Bunge processes the grain, and Chevron utilizes the oil for renewable fuel production. Before the acquisition, CoverCress had raised approximately $48 million through multiple funding rounds from investors including Monsanto, Prelude Ventures, and Fulcrum Global Capital. The company continues to operate as an independent entity, leveraging its key partnerships to scale commercialization.
Source: Dealroom company dataNews
Open roles
CoverCress (previously Arvegenix) in the Creve Coeur ecosystem
The CoverCress (previously Arvegenix) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Prelude Ventures
St. Louis Arch Angels
Leaps by Bayer
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about CoverCress (previously Arvegenix) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CoverCress (previously Arvegenix) on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.